Soloway Thomas P
Insider CIK 1454280 · TSPT SVP, Operations and CFO · BOLD Senior Vice President, CFO · STSA Director · THRD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| THRD Third Harmonic Bio, Inc. | J Other deriv | 2025-08-11 | 2025-08-14 | 120,166 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 76,582 | — | $0 | 76,582 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2023-03-06 | 2023-03-08 | 13,667 | — | $0 | 13,667 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | D To issuer deriv | 2023-03-06 | 2023-03-08 | 76,582 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | A Award deriv | 2022-10-26 | 2022-10-27 | 13,667 | — | $0 | 13,667 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2020-07-02 | 2020-07-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 6,263 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 73,781 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 3,829 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 65,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 75,000 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 183,384 | $60.00 | $11.00M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2020-01-08 | 2020-01-10 | 6,219 | — | $0 | 73,781 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2020-01-08 | 2020-01-10 | 144,669 | — | $0 | 3,829 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2020-01-08 | 2020-01-10 | 6,219 | $15.26 | $94.9K | 183,384 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2020-01-08 | 2020-01-10 | 144,669 | $2.76 | $399.3K | 177,165 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise deriv | 2019-12-12 | 2019-12-16 | 41,321 | — | $0 | 148,498 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-12 | 2019-12-16 | 8,681 | $59.37 | $515.4K | 12,633 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | M Exercise | 2019-12-12 | 2019-12-16 | 41,321 | $2.76 | $114.0K | 53,954 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-12 | 2019-12-16 | 21,458 | $59.37 | $1.27M | 32,496 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-05 | 2019-12-09 | 505 | $59.21 | $29.9K | 21,314 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-09-05 | 2019-09-09 | 505 | $31.02 | $15.7K | 21,819 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-06-05 | 2019-06-07 | 1,009 | $37.31 | $37.6K | 22,324 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 65,000 | — | $0 | 65,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 23,333 | — | $0 | 23,333 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-11-16 | 2017-11-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-01-25 | 2017-01-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-07-15 | 2013-07-18 | 115,000 | — | $0 | 115,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2013-01-07 | 2013-01-08 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TSPT Transcept Pharmaceuticals | A Award deriv | 2012-02-01 | 2012-02-02 | 60,000 | — | $0 | 60,000 | SEC↗ |